General characteristics of research participants (n=63)
Variables | Patients, n (%) |
Age (months)* | 16 (6–165) |
Gender | |
Male | 34 (54) |
Female | 29 (46) |
Body weight (kg)* | 8.7 (6.3–38) |
History of growth failure | |
Yes | 48 (76.2) |
No | 15 (23.8) |
Diagnosis | |
Biliary atresia | 51 (80.9) |
Caroli disease | 2 (3.2) |
Alagille syndrome | 3 (4.8) |
Choledochal cyst | 3 (4.8) |
Autoimmune hepatitis | 1 (1.6) |
Budd-Chiari syndrome | 1 (1.6) |
Neonatal hepatitis | 1 (1.6) |
Extrahepatic portal vein thrombosis | 1 (1.6) |
History of surgery | |
Yes | 9 (14.3) |
No | 54 (85.7) |
Donor | |
Maternal | 33 (52.4) |
Paternal | 26 (41.3) |
Others (aunt/uncle) | 4 (6.3) |
Donor age (years)* | 32 (21–55) |
ABO incompatibility | |
Yes | 2 (3.2) |
No | 61 (96.8) |
Donor macrosteatosis | |
None (≤5%) | 47 (74.6) |
Very mild (>5% to 15%) | 12 (19.0) |
Mild (>15% to 30%) | 2 (3.17) |
Moderate (>30% to 60%) | 2 (3.17) |
Severe (>60%) | 0 |
Billiary anastomosis | |
1 | 41 (65.1) |
2 | 22 (34.9) |
Early relaparotomy | 15 (23.8) |
PELD score* | 17 (6–36) |
Surgery duration (min)* (n=60) | 720 (480–1440) |
Blood loss (mL/kg body weight)* (n=58) | 81 (17–581) |
Warm ischemic time (min)† (n=59) | 61±27 |
Cold ischemic time (min)* (n=59) | 62 (19–273) |
*Data are presented with median (range).
†Data are presented with mean±SD.
PELD, pediatric end-stage liver disease; SD, standard deviation.